Purification and identification of a human dermal extract component inhibitory to fibroblast proliferation

J. E. Stewart, Denis Wheatley, I. F. Muir, J. D. Holmes

    Research output: Contribution to journalArticle

    12 Citations (Scopus)

    Abstract

    It was previously shown that a citric acid buffer extract of human dermis (extract D) inhibited growth of human diploid fibroblasts in monolayer culture (Muir ct nl,, 1997), Further fractionation has shown that the active principle is probably a proteoglycan, and that retention of its inhibitory activity is dependent on the use protease inhibitors throughout the extraction procedure. Elution of extract D from a DEAF-cellulose column produced four major peaks, each of which was subjected to SDS-PAGE as well as being tested for inhibitory activity on the growth of fibroblasts in culture. Peaks III and IV had no inhibitory effect, but peak I contained highly active material. Gels of this peak showed prominent bands of 120 kDa (corresponding to dermatan sulphate proteoglycan II, DS-PG II) and at 45 kDa (corresponding to the core protein). The latter band became more prominent when extract D which had been treated with chrondroitinase ABC was electrophoresed. Their identities were verified by Western blotting. Peak II also contained some slower-acting inhibitory material which has as yet to be identified, but contains little or no protein corresponding to the decorin core-protein. The data indicate that the intact decorin molecule, DS-PG II, is the main inhibitory principle in human skin. (C) 2001 Academic Press.

    Original languageEnglish
    Pages (from-to)607-612
    Number of pages5
    JournalCell Biology International
    Volume25
    Issue number7
    DOIs
    Publication statusPublished - 2001

    Keywords

    • human dermis
    • decorin
    • DSPG-II
    • fibroblast
    • cell proliferation
    • regulation
    • GROWTH-FACTOR-BETA
    • SULFATE PROTEOGLYCAN

    Cite this

    Purification and identification of a human dermal extract component inhibitory to fibroblast proliferation. / Stewart, J. E.; Wheatley, Denis; Muir, I. F.; Holmes, J. D.

    In: Cell Biology International, Vol. 25, No. 7, 2001, p. 607-612.

    Research output: Contribution to journalArticle

    Stewart, J. E. ; Wheatley, Denis ; Muir, I. F. ; Holmes, J. D. / Purification and identification of a human dermal extract component inhibitory to fibroblast proliferation. In: Cell Biology International. 2001 ; Vol. 25, No. 7. pp. 607-612.
    @article{aaaf4fd39502447ba3c4469589cbb224,
    title = "Purification and identification of a human dermal extract component inhibitory to fibroblast proliferation",
    abstract = "It was previously shown that a citric acid buffer extract of human dermis (extract D) inhibited growth of human diploid fibroblasts in monolayer culture (Muir ct nl,, 1997), Further fractionation has shown that the active principle is probably a proteoglycan, and that retention of its inhibitory activity is dependent on the use protease inhibitors throughout the extraction procedure. Elution of extract D from a DEAF-cellulose column produced four major peaks, each of which was subjected to SDS-PAGE as well as being tested for inhibitory activity on the growth of fibroblasts in culture. Peaks III and IV had no inhibitory effect, but peak I contained highly active material. Gels of this peak showed prominent bands of 120 kDa (corresponding to dermatan sulphate proteoglycan II, DS-PG II) and at 45 kDa (corresponding to the core protein). The latter band became more prominent when extract D which had been treated with chrondroitinase ABC was electrophoresed. Their identities were verified by Western blotting. Peak II also contained some slower-acting inhibitory material which has as yet to be identified, but contains little or no protein corresponding to the decorin core-protein. The data indicate that the intact decorin molecule, DS-PG II, is the main inhibitory principle in human skin. (C) 2001 Academic Press.",
    keywords = "human dermis, decorin, DSPG-II, fibroblast, cell proliferation, regulation, GROWTH-FACTOR-BETA, SULFATE PROTEOGLYCAN",
    author = "Stewart, {J. E.} and Denis Wheatley and Muir, {I. F.} and Holmes, {J. D.}",
    year = "2001",
    doi = "10.1006/cbir.2000.0693",
    language = "English",
    volume = "25",
    pages = "607--612",
    journal = "Cell Biology International",
    issn = "1065-6995",
    publisher = "Portland Press Ltd.",
    number = "7",

    }

    TY - JOUR

    T1 - Purification and identification of a human dermal extract component inhibitory to fibroblast proliferation

    AU - Stewart, J. E.

    AU - Wheatley, Denis

    AU - Muir, I. F.

    AU - Holmes, J. D.

    PY - 2001

    Y1 - 2001

    N2 - It was previously shown that a citric acid buffer extract of human dermis (extract D) inhibited growth of human diploid fibroblasts in monolayer culture (Muir ct nl,, 1997), Further fractionation has shown that the active principle is probably a proteoglycan, and that retention of its inhibitory activity is dependent on the use protease inhibitors throughout the extraction procedure. Elution of extract D from a DEAF-cellulose column produced four major peaks, each of which was subjected to SDS-PAGE as well as being tested for inhibitory activity on the growth of fibroblasts in culture. Peaks III and IV had no inhibitory effect, but peak I contained highly active material. Gels of this peak showed prominent bands of 120 kDa (corresponding to dermatan sulphate proteoglycan II, DS-PG II) and at 45 kDa (corresponding to the core protein). The latter band became more prominent when extract D which had been treated with chrondroitinase ABC was electrophoresed. Their identities were verified by Western blotting. Peak II also contained some slower-acting inhibitory material which has as yet to be identified, but contains little or no protein corresponding to the decorin core-protein. The data indicate that the intact decorin molecule, DS-PG II, is the main inhibitory principle in human skin. (C) 2001 Academic Press.

    AB - It was previously shown that a citric acid buffer extract of human dermis (extract D) inhibited growth of human diploid fibroblasts in monolayer culture (Muir ct nl,, 1997), Further fractionation has shown that the active principle is probably a proteoglycan, and that retention of its inhibitory activity is dependent on the use protease inhibitors throughout the extraction procedure. Elution of extract D from a DEAF-cellulose column produced four major peaks, each of which was subjected to SDS-PAGE as well as being tested for inhibitory activity on the growth of fibroblasts in culture. Peaks III and IV had no inhibitory effect, but peak I contained highly active material. Gels of this peak showed prominent bands of 120 kDa (corresponding to dermatan sulphate proteoglycan II, DS-PG II) and at 45 kDa (corresponding to the core protein). The latter band became more prominent when extract D which had been treated with chrondroitinase ABC was electrophoresed. Their identities were verified by Western blotting. Peak II also contained some slower-acting inhibitory material which has as yet to be identified, but contains little or no protein corresponding to the decorin core-protein. The data indicate that the intact decorin molecule, DS-PG II, is the main inhibitory principle in human skin. (C) 2001 Academic Press.

    KW - human dermis

    KW - decorin

    KW - DSPG-II

    KW - fibroblast

    KW - cell proliferation

    KW - regulation

    KW - GROWTH-FACTOR-BETA

    KW - SULFATE PROTEOGLYCAN

    U2 - 10.1006/cbir.2000.0693

    DO - 10.1006/cbir.2000.0693

    M3 - Article

    VL - 25

    SP - 607

    EP - 612

    JO - Cell Biology International

    JF - Cell Biology International

    SN - 1065-6995

    IS - 7

    ER -